Stamulumab
an antibody designed to bind to and inhibit the activity of myostatin (growth differentiation factor 8); it is being tested for the treatment of Duchenne muscular dystrophy
Also Known As:
MYO-029; human recombinant immunoglobulin G1 anti-GDF8 monoclonal antibody
Networked: 6
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Sunada, Yoshihide:
3 articles
(11/2011 - 11/2006)
|
2. | Amato, Anthony A:
2 articles
(01/2009 - 05/2008)
|
3. | Bhattacharya, I:
1 article
(12/2016)
|
4. | Bosley, J:
1 article
(12/2016)
|
5. | Gordi, T:
1 article
(12/2016)
|
6. | Rong, H:
1 article
(12/2016)
|
7. | Singh, P:
1 article
(12/2016)
|
8. | Krivickas, Lisa S:
1 article
(01/2009)
|
9. | Walsh, Ronan:
1 article
(01/2009)
|
10. | Allen, Robert:
1 article
(05/2008)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures